NCAM1 and neoplasm: To support this hypothesis, IHC analysis using anti‐CD56 on treated PDX tissues showed a more pronounced clustering of NK cells at tumor sites in the Gel@Cmab/PCZ treatment group, further substantiating our conjecture.